- Report
- October 2024
- 199 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- April 2025
- 93 Pages
Global
From €5369EUR$5,600USD£4,486GBP
- Report
- August 2024
- 141 Pages
Global
From €2875EUR$2,999USD£2,402GBP
- Report
- April 2025
- 194 Pages
Global
From €4745EUR$4,950USD£3,965GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- March 2024
- 146 Pages
Global
From €3787EUR$3,950USD£3,164GBP
- Report
- February 2024
- 137 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- January 2024
- 200 Pages
Global
From €3978EUR$4,150USD£3,324GBP
- Report
- September 2023
- 98 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- July 2024
- 228 Pages
Global
From €2545EUR$2,655USD£2,127GBP
- Report
- December 2023
- 228 Pages
Global
From €3422EUR$3,570USD£2,860GBP
- Report
- November 2023
- 230 Pages
Global
From €3538EUR$3,690USD£2,956GBP
Cerebral Angiography is a type of radiography used to diagnose and treat diseases of the brain and its blood vessels. It is a minimally invasive procedure that uses X-ray imaging to create detailed images of the brain's blood vessels. The procedure is used to diagnose conditions such as aneurysms, arteriovenous malformations, and stroke. It can also be used to guide treatment, such as the placement of stents or coils to treat aneurysms.
Cerebral Angiography is a growing market within the radiography industry. It is used in a variety of clinical settings, including hospitals, imaging centers, and private practices. The procedure is becoming increasingly popular due to its accuracy and safety.
Some companies in the Cerebral Angiography market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems. Show Less Read more
